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Abstract
In the conventional paradigm of humoral immunity, B cells recognize their cognate antigen target in its native form.
However, it is well known that relatively unstable peptides bearing only partial structural resemblance to the native protein
can trigger antibodies recognizing higher-order structures found in the native protein. On the basis of sound
thermodynamic principles, this work reveals that stability of immunogenic proteinlike motifs is a critical parameter
rationalizing the diverse humoral immune responses induced by different linear peptide epitopes. In this paradigm,
peptides with a minimal amount of stability (DGX,0 kcal/mol) around a proteinlike motif (X) are capable of inducing
antibodies with similar affinity for both peptide and native protein, more weakly stable peptides (DGX.0 kcal/mol) trigger
antibodies recognizing full protein but not peptide, and unstable peptides (DGX.8 kcal/mol) fail to generate antibodies
against either peptide or protein. Immunization experiments involving peptides derived from the autoantigen histidyl-tRNA
synthetase verify that selected peptides with varying relative stabilities predicted by molecular dynamics simulations induce
antibody responses consistent with this theory. Collectively, these studies provide insight pertinent to the structural basis of
immunogenicity and, at the same time, validate this form of thermodynamic and molecular modeling as an approach to
probe the development/evolution of humoral immune responses.
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Introduction
In the conventional paradigm of humoral immune responses, B
cells recognize conformational epitopes of protein antigens through
interactions with surface expressed immunoglobulin receptors [1].
For most antigens, this process requires T cell help that results in
sequential steps of class switching, affinity maturation, and epitope
spreading [2–5]. The nature of the antigen itself influences this
highly orchestrated process, as glycosylation patterns and other
post-translational protein modifications often impact the affinity
and specificity of the immunoglobulin binding domain for relevant
three-dimensional epitopes [6–9].
Based on this mechanism of B cell activation and immunoglob-
ulin production, native protein should be highly immunogenic
relative to short peptide sequences less than 20 amino acids in
length. While this concept may hold true for many antigens, the
existing literature does provide examples of peptides capable of
stimulating antibody production not only against the immunizing
peptide, but also against corresponding regions of the native
protein [10,11]. This apparent contradiction is often resolved by
assuming that peptides are capable of adopting stable structures
mimicking those found in the native protein [12–15]. In particular,
Gros and collaborators [16] have shown that the stability of
synthetic, cyclized peptides mimicking an immunodominant loop
of the Neisseria meningitidis protein PorA correlates with immuno-
genicity. However, because typical linear peptides are inherently
unstable, with stabilities that are virtually impossible to assess due
to the lack of a well defined folded (reference) state, more complete
elucidation of the molecular mechanism(s) underlying these
empirical observations remains elusive. Underscoring the com-
plexity of this problem, an analysis involving a helical motif of the
enzyme barnase represents the only published measurement of
peptide folding free energy (DGf =21 kcal/mol) [17].
In the current study, we have reexamined this issue through
detailed analysis of serologic profiles generated in mice immunized
with overlapping 18 amino acid peptides comprising the amino
terminal portion of histidyl-tRNA synthetase (HRS = Jo-1), an
autoantigen implicated in the pathogenesis of idiopathic inflam-
matory myopathy and the anti-synthetase syndrome [18]. Our
published murine model of this disease demonstrates that many of
these peptides are highly immunogenic, inducing antibodies that
cross react with recombinant murine HRS protein in a
predictable, species-specific manner [19].
Beyond the definition of immunodominant peptides dictating B
cell recognition of HRS peptide/protein combinations, this
analysis has permitted correlation of the humoral immune
response with structural and thermodynamic determinants of
peptide immunogenicity. Of note, molecular modeling calcula-
tions indicate that although peptides are intrinsically disordered
and therefore less stable than full protein, they are capable of
adopting relevant structural ‘‘mimetopes’’ with enough stability to
trigger humoral responses against corresponding regions of native
protein. Immunization experiments verify that selected peptides
predicted to form higher order structures similar to those existing
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in parent proteins induce significant antibody responses against
intact protein. Moreover, competition experiments show that
several of these immunogenic peptides are able to bind to
stimulated antibodies with similar affinity to that of the full protein.
Collectively, these studies provide insight pertinent to the
structural basis of immunogenicity and, at the same time, validate
this form of thermodynamic and molecular modeling as a tool to
probe the development/evolution of humoral immune responses.
Results
Thermodynamic Relationship between Peptide Stability
and Antigenicity
To establish a thermodynamic basis for previous observations
linking peptide immunization with humoral immune responses
against native protein structural motifs, we examined the
relationship between peptide folding stability and antibody-antigen
binding. Although the capacity of intrinsically disordered peptides
to generate and effectively bind antibodies recognizing three-
dimensional epitopes appears counterintuitive, the kinetic scheme
in Figure 1 (equations are in Figure S1A) demonstrate that, under
very general conditions, complete peptide stability is not a
necessary condition for effective binding. Indeed, classification of
peptides according to the free energy (DGX) of their protein-like
motifs defines three classes of peptides possessing very different
immunogenic properties. These categories include: (a) ‘‘stable’’
peptides (for which DGX,0 kcal/mol) that can form the same
number of peptide-antibody ([XAb]) complexes as stable protein
despite a wide range of folding free energy values; (b) ‘‘weakly-
stable’’ peptides with DGX.0 kcal/mol (but ,8 kcal/mol) that
have a drastic decrease in antibody binding events relative to the
full protein; and, (c) ‘‘unstable’’ or ‘‘non-immunogenic’’ peptides
with DGX.8 kcal/mol and resulting unfolding rates of 10
9 s21 or
higher that preclude any effective binding [20,21]. While the
precise stability thresholds are somewhat dependent on concen-
tration and binding affinities, the relative stability grouping of each
peptide type is independent of folding rates.
Antibody Profiles Generated through HRS Peptide
Immunization
As an example of the epitope classification scheme derived from
this thermodynamic analysis, we have mapped relevant B cell
epitopes of histidyl-tRNA synthetase (HRS) through peptide
immunization of NOD.Idd3/5 mice. As shown in Figure 2, the
panel of HRS peptides consists of overlapping 18 amino acid
sequences corresponding to the immunodominant amino terminal
portion of HRS. The relationship between these peptides and
different structural motifs of intact protein is highlighted by the
accompanying model of HRS.
Review of Figure 3A indicates that several peptides comprising
the amino terminal 98 amino acids of HRS generate antibody
responses against a HRS fusion protein (MA/MBP = amino
terminal amino acids 1–151 linked to maltose binding protein)
by two weeks, most notably peptides 1 (a.a. 1–18), 4 (a.a. 31–48), 6
(a.a. 51–68), 7 (a.a. 61–78), 8 (a.a. 71–88), and 9 (a.a. 81–98).
Temporal assessment of anti-HRS protein antibody responses
induced by these peptides and comparison to antibody responses
against the immunizing peptide (Figure 3B) demonstrates several
different recognition patterns consistent with the thermodynam-
ically-defined categories in Figure 1. In the case of peptides 1 and
9, for example, titers of anti-HRS protein and anti-peptide
antibodies parallel each other by tending to increase over time.
Conversely, peptides 4, 6, and 7 produce more variable temporal
Figure 1. Thermodynamics and binding kinetics of a stable
protein compared to weakly stable peptides sharing the same
binding motifs. (A) This sketch represents the folding free energy
landscape of a stable protein (solid line) relative to a less stable protein/
peptide (dashed line) sharing the same folded motif. (B) Coupling of
protein folding free energy and protein (X)-antibody (Ab) binding
kinetics is shown in the designated graph where the amount of protein-
antibody complex (XAb) complex formed is plotted as a function of the
folding stability of X, with fixed concentrations of X and Ab equal to
1 mM. The solid line reflects association and dissociation rates of
106 M21s21 and 1021 s21 (Kd = 100 nM), respectively, whereas the
dotted line indicates a dissociation rate of 1023 s21 (Kd = 1 nM). Dashed
lines delineate different binding regimes as a function of peptide/
protein stability, identifying a ‘‘stable’’ category with DGX,0 kcal/mol
that corresponds to peptides capable of binding to antibody with the
same affinity as protein. Above this threshold exist ‘‘weakly stable’’
peptides that can trigger anti-protein antibodies but are unable to
compete with protein for antibody binding. Peptides exceeding the
folding free energy boundary of the latter category are unstable and
therefore non-immunogenic.
doi:10.1371/journal.pcbi.1000231.g001
Author Summary
In the current paradigm of immune system recognition, T
cell receptors bind to relatively short peptide sequences
complexed with major histocompatibility complex pro-
teins on the surface of antigen presenting cells, while B cell
receptors recognize unprocessed protein structures. Yet,
ample data exist showing that peptide immunization can
trigger B cell responses targeting both the immunizing
peptide and peptidelike motifs contained within intact
protein—despite the fact that the folding stability of such
peptides is often quite low. Using thermodynamic
modeling and the technique of molecular dynamics
simulations, this work provides a cogent framework for
understanding the relative capacity of inherently unstable
peptide structures to faithfully trigger B cell antibody
production against specific conformational motifs found in
native/intact proteins.
Peptide Immunogenicity
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patterns of anti-HRS protein antibody responses, generally
without corresponding anti-peptide responses over the monitored
time course (significant anti-P6 titers develop in only 1/8 P6
immunized-mice at 8 weeks). Finally, peptides 2 and 5 represent
sequences that fail to generate anti-protein or anti-peptide
antibodies at any time point.
Competition ELISAs Reflect Structural Stability of HRS
Peptides
Complementing these results, competition ELISAs provide
further insight regarding the relative antigenicity of HRS
peptides and protein. As shown in Figure 3C, pre-incubating
sera from peptide-immunized mice with increasing concentra-
tions of MA/MBP effectively reduces residual binding to MA/
MBP substrate, confirming the specificity of antibody responses
generated by peptides 1, 7, 8, and 9. However, when peptides
are used in the pre-incubation phase, the effect is more variable.
With peptide 7- and 8-immunized sera, for example, peptide pre-
incubation has little or no detectable effect on the ability of
antibodies to bind MA/MBP. On the other hand, molar
equivalent amounts of peptide 1 and 9 compete for antibody
binding to both MA/MBP and peptide substrate as effectively as
protein—consistent with the ability of peptides 1 and 9 to adopt
relatively stable structures in solution that resemble correspond-
ing regions of intact protein.
Figure 2. Linear sequence and structural model of murine HRS. Panel (A) depicts the linear sequence of overlapping 18 amino acid peptides
comprising the amino terminal 108 amino acids of murine HRS. Color-coding corresponds to the composite three-dimensional model shown in panel
(B) (derived from the structures of human and Thermoplasma acidophilum HRS as described in Methods), demonstrating the relationship of these
sequences to various structural motifs. Sequences extending beyond peptide 10 are colored in gray (amino acids 108–151) or semi-transparent white
(amino acids 152–510). Bars overlying the amino acid sequence in panel A signify a-helices, arrows indicate b-sheets, and underlining identifies
proline residues.
doi:10.1371/journal.pcbi.1000231.g002
Figure 3. Temporal evolution of HRS peptide-induced antibody responses and characterization of relative peptide vs. protein
binding affinity. Symbols denote data points corresponding to the mean OD450 values of triplicate ELISA samples (after subtraction of no antigen
and anti-MBP background) generated by sera obtained from individual peptide-immunized mice, and lines serve as a visual guide. Individual panels
in A) depict levels of peptide-induced antibodies recognizing a HRS fusion protein (consisting of the amino terminal 151 amino acids of murine HRS
linked to maltose binding protein =MA/MBP) at various time points after a single immunization with peptide/CFA emulsions. The plots in B) show
corresponding anti-peptide antibody titers induced by immunization with the indicated peptides (line colors identify matched serum samples). Error
bars are negligible and have therefore been omitted. Finally, panel C) demonstrates competition assays in which serum obtained from HRS peptide-
immunized mice (8 weeks following immunization unless otherwise indicated) is pre-incubated with different molar concentrations of immunizing
peptide (closed triangles) or MA/MBP (open circles) before being subjected to ELISA. Substrate antigens consist of the immunizing peptide (red lines
and symbols) or MA/MBP (blue lines and symbols). Molar concentrations of peptide and protein used for pre-incubation are equivalent at individual
points along the x-axis. OD450 values again represent the mean of triplicate samples; negligible error bars are not shown.
doi:10.1371/journal.pcbi.1000231.g003
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Molecular Dynamics (MD) Simulations Provide Measure
of Structural Stability of Proteinlike Motifs
To correlate these peptide immunization studies with the
thermodynamically-defined categories of immunogenicity outlined
in Figure 1, we employ MD simulations. However, the inherent
difficulty in directly measuring peptide folding free energy is also
present in MD–namely, the ‘‘folded’’ state of interest (i.e., the motif
that binds the pool of B cell receptors) is not well defined. A second
drawback is that an absolute thermodynamic estimate of free energy
needs to account for the unstructured, unfolded state. Cutting edge
MD techniques can compute free energy differences between well
defined states and may be able to account for the configurational
entropy of peptides, but currently cannot properly estimate the
required entropy of ,7000 explicit water molecules [22].
Despite this caveat, the dashed line in Figure 1A indicates that
the stability of states other than the protein-like motif (X) is
irrelevant from the point of view of establishing a correlation
between antibody binding of stable protein versus unstable linear
peptides. Other states could, of course, lead to an immune
response targeting an unknown structure. We note, however, that
this scenario does not apply here, since ELISAs involving peptide
substrates do not seem to yield a signal if there is no response
against protein. The only exceptions are motifs represented by
peptides 3 and 8 which, as argued below, are obscured in their
protein form. Hence, MD simulations represent a valuable and
insightful alternative method for probing the relative stability of
different epitopes in their corresponding protein fold and for better
defining the relevant ‘‘folded’’ state. In particular, because
recognition events occur within a nanosecond time scale [21,23],
peptides are simulated over a 10 nanosecond period [16] that
allows extraction of the most stable backbone protein-like motifs of
four consecutive amino acids (i.e., a small binding domain).
Figure 4 shows optimal backbone structural alignments of MD
snapshots superimposed on the three-dimensional model of
murine HRS. The alignment for each peptide is based on the 4
consecutive residues with the smallest cumulative root-mean-
square deviation (RMSD) over a 10 nanosecond period [16]
(summarized by the bar graph in Figure 5). Although peptide
conformations fluctuate to varying degrees, the composite profiles of the
most structurally stable protein-like motifs provide a visual analogue showing
relative stability and similarity to defined motifs found in murine HRS.
Interestingly, each of the peptides with a cumulative RMSD value
less than 4 A˚ (i.e., peptides 1, 3, 7, 8, and 9) triggers affinity
maturation towards MA/MBP and/or peptide, whereas peptides
with less stable backbone structures (peptides 2, 4, 5, and 6)
typically do not promote this temporal pattern of increasing
antibody titer. Of note, MD simulations indicate that for those
peptides capable of adopting higher order structure, the identified
motifs can persist for several nanoseconds—a time period
sufficient for antibody recognition [21,23].
A more detailed analysis of the hydrogen bond (HB) networks
[24] sampled during the MD runs yields similar conclusions, with
the caveat that proline-stabilized structures such as peptide 9 do
not involve HBs. Stable HBs from motifs both present and missing
in the native protein (Figure 2) are listed in Table 1. Consistent
with the RMSD results, peptides 1, 3, and 8 preserve protein-like
motifs that involve several HBs for a significant amount of the
simulation time. Peptide 7 also preserves a HB at the beginning of
a helix that, together with Pro7, contributes to stability of the
motif. Peptide 4 has one stable HB at the end of a helix (no
proline), providing a degree of structural stability that is consistent
with the ability of this peptide to generate an initial antibody
response against protein two weeks following immunization
(Figure 3A). Despite the fact that peptides 2 and 5 have some
secondary structure, these peptides do not preserve their
corresponding HBs and fail to trigger antibodies against protein
or peptide.
Coupled with the thermodynamic modeling of Figure 1, these
findings strongly suggest that the highly immunogenic peptides 1
and 9 fall into the stable category where DGX values allow
Figure 4. Molecular dynamics simulations of HRS-derived
peptides. Three-dimensional conformations of individual 18 amino
acid HRS peptides (presented in Figure 1) were simulated for 10
nanoseconds. Each simulation consists of 10 snapshots (from light blue
to red) separated by 1 nanosecond intervals and superimposed on a
structure matching the corresponding motif present in full protein
(shown here in blue, but also depicted in Figure 1). Peptide sequence is
again shown below respective simulations, with hydrophobic residues
in red and conserved regions in a larger font. Structural motifs for each
conserved region are designated by the following symbols: red
bars = helices, yellow arrows =b-sheets, and Pro =proline residues. For
peptide 5 (P5), Gln12 and Phe14 are shown as sticks (in the figure) to
indicate that the conserved backbone is blocked by flanking side
chains.
doi:10.1371/journal.pcbi.1000231.g004
Figure 5. Cumulative root-mean-squared-deviation (RMSD) of
optimal structural alignments of proteinlike motifs represent-
ed in linear peptides. Identification of 4 consecutive amino acid
stretches yielding the minimum cumulative pairwise root-mean-
squared-deviation (RMSD) for snapshots included in the 10 nanosecond
period forms the basis of optimal structural alignment for individual
peptides. Lower values indicate more stable peptides with less
structural variation.
doi:10.1371/journal.pcbi.1000231.g005
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maximal peptide-antibody complex formation. In contrast, this
combined analysis indicates that peptides 4 and 6 are weakly
stable, with DGX values that favor diminished antibody binding of
peptide relative to full protein. This classification is fully consistent
with ELISAs (Figure 3) showing that antibodies generated by
immunization with peptides 4 and 6 generally bind protein, but
not peptide, substrate antigens. Also dovetailing with experimental
results, the non-immunogenic peptides 2 and 5 lack any form of
structure resembling native HRS (Table 1), and no new structural
motifs are detected within the limited simulation time. The latter
observation also reflects the fact that although MD simulations
and resulting RMSD calculations based on backbone stability
provide a framework for ranking the likelihood of forming high
affinity peptide-antibody complexes, side chains remain a critical
determinant influencing the specificity of this interaction [25].
More specifically, the loop structure of peptide 5 (shown in
Figure 4) is flanked by highly unstable side chains blocking the
relatively conserved backbone. With peptide 3, on the other hand,
intramolecular HBs linking side chains of Ser7 and Gln10 to side
chains of the structurally conserved motif E12E13E14 (44% and
29%, respectively) might be responsible for the weak anti-peptide
response shown in Figure 3B.
Discussion
Collectively, these studies show that several peptides corre-
sponding to the amino terminal portion of murine HRS are
capable of inducing anti-protein antibodies of varying affinity and
temporal persistence. As shown by molecular dynamics simula-
tions, sequences of the most immunogenic peptides correspond to
highly ordered structural motifs in the parent protein. Competitive
ELISAs provide direct evidence that these peptides share
structural determinants with native protein by demonstrating the
relative equivalence of antibody affinity for HRS protein (MA/
MBP) and selected peptides (i.e., antibodies recognize or identify,
rather than actively define, the immunodominant motif). Of
greater significance, first principle calculations and molecular
dynamics simulations underscore the thermodynamic and struc-
tural basis of these experimental observations.
Among the most interesting findings emerging from the
experiments summarized in Figure 3 is the diversity of antibody
responses engendered by immunization with different peptides.
While peptides 1 and 9, for example, bind induced antibodies
almost as effectively as full protein, peptides 4 and 7 generate
strong antibody responses to protein that fail to recognize peptide
in the context of ELISA. In contrast, peptides 2 and 5 do not
support antibody production against either protein or peptide. For
those peptides generating strong antibody responses against the
HRS fusion protein MA/MBP, structural mapping indicates
correspondence to well-defined domains that involve either a-
helices (peptides 1, 3, 4, 7, 8) or linear motifs stabilized by a proline
residue (peptides 6, 7, 9). To some extent, this result is expected
because (in solution) such motifs should retain some of the stability
present in native protein. The key question, however, is how
peptides bearing only partial structural resemblance to native
protein can bind antibodies with similar affinity to that of intact
protein.
Answering this question relies on the simple observation that
although peptides should be destabilized when isolated from
protein (e.g., due to solvent exposure of normally buried amino
acid residues), this instability does not translate into an equivalent
drop in affinity towards the repertoire of B cells receptors. Indeed,
thermodynamic calculations in Figure 1 reveal a relatively broad
range of DGf values (,0 kcal/mol) in which peptides are capable
of triggering an immune response similar to full protein. Hence, as
long as the peptide fold resembles that of the full protein, this class
of peptides (defined as ‘‘stable’’ in Figure 1) should have antigenic
properties similar to those of full protein. Beyond those ‘‘stable’’
peptides with DGf,0 kcal/mol, Figure 1 identifies a ‘‘weakly-
stable’’ regime where peptides are typically 10–100 times less likely
than HRS protein to bind peptide-induced antibodies. In other
words, the same antibodies that rarely bind isolated peptides can
readily recognize the corresponding motif in the context of stable
protein. Unlike their more stable counterparts, however, such
Table 1. Proteinlike and peptide-unique motifs stabilized by hydrogen bonds (HBs) (error 10%).
Peptide
Number HBs Present in Protein
Average Stability
of HBs HBs Not in Protein
Average Stability
of HBs Comment
1 6–14: 5 HBs helix 89% - - Stable helix
2 8–12: 1 HB helix 29% 12–14 bb-bb 41% Unstable peptide
3 11–17: 3 HBs helix 52% 6–13 bb-sc 24% 3 helix bonds, but sc of
conserved motif E12E13E14 are
forming intramolecular bonds
4 12–16: 1 HB helix 54% 12–18 bb-sc 66% Last helix turn is stable
5 1–5: 1 HB helix 27% 2–9 bb-sc 44% Unstable peptide
6 4–6 bb-bb (?) 43% - - Peptide is not resolved
experimentally
7 6–10: 1 HB helix 78% 7–12 bb-bb 56% First helix turn is stabilized by
HB and Pro
8 4–11: 4 HBs helix 75% 6–11 bb-bb 51% Stable helix
9 - - 3–17 bb-bb 56% Stable Pro-peptide; HB 3–17
stabilizes the presentation of
the Pro-motif (12–14)
10 9–13: 1 HB helix 22% 8–11 bb-bb 27% Unstable peptide, Pro-motif is
more unstable than in
peptide 9
bb: backbone; sc: side chain.
doi:10.1371/journal.pcbi.1000231.t001
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weakly stable motifs typically do not promote affinity maturation
against protein (compare peptides 1 and 9 to peptides 4 and 6,
Figure 3).
From a modeling point of view, molecular dynamics (MD)
simulation in explicit solvent represents the most accurate
approach to assess peptide stability. Although this technique has
time limitations that prevent a full thermodynamic analysis of each
peptide, the 10 nanosecond period used here is sufficient to assess
the stability of protein-like conformations relevant to the
comparison of peptide- versus protein-targeted antibody respons-
es. Clearly, the MD simulations demonstrate a wide range of
structural stabilities over 10 nanosecond runs; in the case of
peptides 1 and 9, however, the composite structural motifs greatly
resemble those presented by full protein, confirming that helical as
well as some proline-based linear motifs can preserve their
structural integrity over a time frame that is fully compatible with
molecular recognition [21,23].
Perhaps the differences in stability and antibody binding affinity
between overlapping sequences of peptide 9 (amino acids 81–98)
and peptide 10 (amino acids 91–108) best illustrate the power as
well as predictive potential of MD simulation. While competition
ELISAs demonstrate that sera derived from peptide 9-immunized
mice recognize both peptide 10 and peptide 9 (consistent with the
immunodominant proline-containing epitope suggested by MD
that encompasses amino acids 93–96), the relative affinity for
peptide 9 exceeds that for peptide 10 by a log order of magnitude
(data not shown)—a result that again correlates with MD
simulations showing that the same proline-containing motif is
significantly destabilized by surrounding sequence in peptide 10,
but not in peptide 9 (see RMSD analysis, Figure 5 and Table 1).
Based on the overall molecular dynamics analysis performed in
this study, peptides 1, 3, 7, 8, and 9 best preserve the folded
structure found in corresponding regions of native protein. This
finding is consistent with the data in Figure 3 showing that each of
these peptides induces some degree of affinity maturation against
either peptide or MA/MBP protein. With some peptides,
however, the failure to stimulate antibodies increasingly cross-
reactive with their corresponding HRS structural motifs appears to
conflict with the MD stability predictions. For example, peptide 3
shows no anti-MA/MBP response at any time point. Yet, analysis
of the HRS structure in Figure 2 suggests that peptide 3 is
sterically hindered by one side of the a-helical motif of peptide 8,
resulting in mutual epitope blockade. Note that the suggested
negatively charged tri-glutamate epitope of peptide 3 is predicted
to face at least four positively charged groups from peptide 8,
further promoting such blockade (see Figure 4 for additional
structural detail). Interestingly, the MA/MBP construct (Figure 2)
still leaves one side of the helix of peptide 8 (i.e., the hydrophobic
side) exposed, suggesting that the anti-MA/MBP and anti-peptide
responses generated by this peptide (Figure 3) might be against
different faces of this structural motif.
Beyond these structural considerations pertinent to peptides 3
and 8, the relatively indiscriminate 2 week antibody responses
shown in Figure 3 support the prevailing view that early humoral
activation involves a lower binding specificity threshold [26–29]
than that required for affinity maturation. The more novel
thermodynamic counterpart of this observation is shown in
Figure 1, where 100-fold differences in binding affinity have little
effect on the formation of antigen-B cell receptor (BCR) complexes
involving stable peptides. Even with weakly stable peptides (e.g.,
peptides 4 and 6) where the impact of binding affinity is potentially
more significant, early antibody responses against protein can
occur—often with titers that are indistinguishable from those
generated by their more stable counterparts. In fact, from the
standpoint of stability, Figure 1 suggests that peptides need only
eclipse the free energy threshold separating unstable from stable/
weakly stable peptides to support early antibody formation.
In contrast, the stability threshold differentiating stable and
weakly stable peptides appears to play a greater role in determining
those peptides capable of generating long term antibody responses,
likely reflecting a requirement for sustained antigen-BCR interac-
tions. Perhaps peptide 4 best illustrates the immunogenic relevance
of this interplay between binding specificity and stability thresholds.
A weakly stable peptide (see Figure 4) that is also the most
hydrophobic of all the assessed HRS peptides, peptide 4 triggers
unusually high antibody titers at week 2; however, none of these
initial responses overcomes the higher activation threshold required
to induce affinity maturation. Although additional factors modulate
the selection process that leads to progression/maturation of the
humoral immune response, the evidence presented here indicates
that this more stringent activation threshold is intimately related to
peptide structural stability.
Complementing the overall experimental evidence of HRS
peptide immunogenicity presented in these studies, the literature is
replete with examples of peptide immunization leading to
antibody responses against parent protein (reviewed in references
[10,11]). While the original studies involving these peptides do not
invoke the novel thermodynamic computation and molecular
dynamics simulations employed in this work, complementary
analysis indicates that several of the reported peptides are capable
of forming higher order structures such as a-helices and proline-
stabilized domains. Moreover, preliminary application of our
theoretical and quantitative framework to alternative peptide
antigens has yielded data (not shown) consistent with these findings
and again demonstrates the power/versatility of this approach in
characterizing epitope recognition. However, what is most
remarkable about the thermodynamic classification scheme
outlined in this work is that peptides with an extraordinarily wide
range of folding free energies (but with structurally conserved core
motifs) behave as ‘‘stable’’ peptides capable of triggering an
immune response against defined motifs present in full protein.
Given such links to the immunobiology of antibody-antigen
recognition, this work suggests a number of important experimental
applications involving the described thermodynamic modeling/
computational analysis. First, more precise mapping of B cell
responses over time will help define the sequence of molecular
recognition events leading to epitope spreading and, in the process,
elucidate the structural component of this process that clearly
involves additional factors such as side chain conformation, relative
hydrophobicity/hydrophilicity, and overall epitope accessibility
(steric freedom). Second, identification of immunodominant peptide
epitopes will permit more detailed categorization of disease subsets
and correlation with disease activity. Finally, this computational tool
will facilitate the prediction and design of immunodominant peptide
epitopes that can be used to define novel autoantibody specificities
in patients with underlying autoimmune diseases. Through such
identification of autoantigen panels, this approach may provide
insight regarding more general epigenetic shifts that generate
multiple autoantigens and ultimately lead to autoimmunity.
Materials and Methods
Antigen Preparation
Overlapping peptides (18–20 mers) comprising the amino
terminal 108 amino acids of murine histidyl-tRNA synthetase
(HRS) were synthesized and HPLC purified by the University of
Pittsburgh Molecular Medicine Institute using Fmoc chemistry. As
previously described, recombinant murine HRS was generated as
Peptide Immunogenicity
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a maltose binding protein (MBP) fusion protein following
subcloning of the appropriate sequence (derived from RT-PCR
amplification of C57BL/6 myocyte RNA) into the bacterial
expression vector pMALc2 (New England Biolabs, Ipswich, MA)
[19]. In situ mutagenesis (Stratagene, La Jolla, CA) with insertion
of a stop codon after base pair 453 yielded a construct encoding
the amino terminal 151 amino acids of murine HRS fused to MBP
(MA/MBP). Expressed proteins were purified with amylose resin
per the manufacturer’s protocol (New England Biolabs, Ipswich,
MA), filter sterilized, and then subjected to additional column
purification for endotoxin removal (Profos AG, Regensburg,
Germany) prior to use in ELISAs.
Mouse Immunization
NOD.Idd3/5 (C57BL/6 Insulin dependent diabetes Idd3/5
non-MHC loci transgressed onto the NOD background) mice
were bred in our animal facility. Eight to ten week old mice were
used in immunization protocols approved by the University of
Pittsburgh IACUC. PBS containing 90 mg of the indicated
peptides was emulsified with CFA in a 1:1 ratio and then injected
at the base of the tail in a total volume of 200 ml. Pertussis toxin
(Sigma-Aldrich, St. Louis, MO) was administered intraperitoneally
(200 ng/mouse in 100 ml PBS) at the time of immunization and
48 hours later. Mice were tail-bled 2 and 4 weeks after
immunization. 8 weeks post immunization, mice were sacrificed,
and additional blood was collected from the heart.
ELISA for Serum Anti-Protein and Anti-Peptide
Antibodies
Standard solid phase ELISAs provided measurements of IgG
anti-MA/MBP and anti-HRS peptide antibody levels in the sera
of mice immunized with different HRS peptides [19]. Briefly,
appropriately diluted serum samples (1:500) from immunized mice
were added to wells containing substrate antigens that included
MA/MBP (2 mg/ml), MBP (2 mg/ml), HRS peptide (2 mg/ml), or
no antigen. Following a 60 minute incubation with horseradish
peroxidase-conjugated goat anti-mouse IgG (0.04 mg/ml, Santa
Cruz Biotechnology, Santa Cruz, CA), enzymatic reactions were
visualized using 3,3,5,5-Tetramethylbenzidine (TMB) (Sigma-
Aldrich) and subsequently terminated with 1 N H2SO4. Color
development was measured at 450 nm by a Wallac 1420
multilabel counter (PerkinElmer, Wellesley, MA), and values were
plotted as OD450 substrate antigen - OD450 no antigen. All assays
were performed in triplicate wells.
Competitive ELISA for Serum Anti-Protein and Anti-
Peptide Antibodies
Plates were coated and blocked as described above. Diluted
serum samples (1:250) were mixed in a 1:1 ratio with serially diluted
MA/MBP or HRS peptide solutions in microtubes and preincu-
bated for 30 minutes at room temperature. Preincubated samples
(final serum dilution of 1:500) were then applied to the plates and
incubated for another 2 hours at room temperature. ELISAs were
completed using the same protocol as described above.
Structural Modeling of Murine Histidyl-tRNA Synthetase
The structural model of Mus musculus histidyl-tRNA synthetase
(HRS = Jo-1) in Figure 1 concatenates the NMR structure of the
Whep-Trs domain (Protein Data Bank-PDB code 1X59, unpub-
lished) of human HRS (amino acids 1–64) and a homology model of
residues 60–498 that is based on the crystal structure of Thermoplasma
acidophilum HRS (PDB code 1WU7, unpublished). With more than
25% sequence identity, including perfect matching of prolines and
glycines in the domains of peptides 1 to 9 listed in Figure 1, the
alignment shown in Figure S1B and the corresponding homology
model represent a robust working model of the full protein [25,26].
Only the linker region encompassing residues 46 to 68 (represented
by peptide 6 (amino acids 51–68) in Figure 2) is not well resolved in
either the NMR or the crystal structures.
Thermodynamic and Kinetic Modeling of Peptide
Stability
Figure 1 solves the standard rate equations for folding and
binding of protein/peptide based on typical thermodynamic
parameters and the assumption that protein (X) binds antibody
(Ab) only when folded in state Xf. The results in Figure 1B depend
only in the folding free energy (independent of the folding rates),
which is varied to cover the full range between 28 and 8 kcal/
mol. Under the additional assumptions that appropriately folded
peptides fully encompass the corresponding protein binding
domain and that antibody-antigen association and dissociation
rates are 106 M21s21 and 1021 s21 (alternative dissociation rate of
1023 s21 is shown as a dotted line), respectively [30], binding
affinity depends more directly on the concentration of Xf ([Xf])
than on peptide stability. For simplicity, we assume a concentra-
tion of antibody ([Ab]) and protein ([X]) equal to 1 mM. However,
the overall shape of the curve does not change significantly with a
higher or lower [Ab]. For [Ab].1 mM, the maximum amount of
complex [XAb] remains the same, but the stability thresholds
(dashed lines in Figure 1) move up. For [Ab],1 mM, the amount
of complex will be limited by [Ab], and the stability threshold will
decrease only slightly.
Molecular Dynamics Simulations
Molecular dynamics simulations were performed using the MD
simulation package GROMACS 3.3.1 [31] on individual peptides
of HRS. Each peptide was centered in a rhombic dodecahedron
box with a 15 A˚ minimum distance from the protein surface to the
box edges. The resulting system was solvated with simple point
charge water molecules and then minimized by using steepest
descent method with the GROMOS96 force field. Counter ions
were added to neutralize the system. The temperature was coupled
to a bath of 300K with a coupling time constant of 0.1 ps. The
pressure was coupled to 1 Bar using a 0.5 ps time constant and
water compressibility of 4.561025 Bar21. A cut-off radius of 10 A˚
was used in the simulations for non-bonded interactions. Initial
velocities were generated randomly from a Maxwell distribution at
300˚K. Simulations consisted of 10 nanosecond runs using the
corresponding protein structure depicted in Figure 2 as a starting
conformation for each peptide. Accuracy/reliability of the
simulations was confirmed with duplicate runs for each peptide.
Supporting Information
Figure S1 Kinetic of folding and binding and sequence
alignment. (A) Folding of protein X and binding of X with
antibody Ab. (B) Alignment of amino terminal 1–151 Histidyl
tRNA synthetase from Mus musculus (MA) and Thermoplasma
acidophilum (PDB code 1WU7)
Found at: doi:10.1371/journal.pcbi.1000231.s001 (0.54 MB TIF)
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